Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Hanall Bio Pharma, Sponsoring Medicines worth 82 million KRW to Community Chest of Korea
Hanall Bio Pharma, Sponsoring Medicines worth 82 million KRW to Community Chest of Korea

 

 

 

On 14th, Hanall Bio Pharma (CEO Kim Seong-uk and CEO Park Seung-guk) has revealed that it has donated medicines worth about 82 million KRW through the Seoul Community Chest of Korea for low-income families who are not able to receive proper medical benefits.


This donation has been made to implement medical welfare of low-income classes and to resolve medical blind spots.

 

Medicines provided by Hanall Bio Pharma are for asthma and allergies, and medicines will be distributed to welfare and medical facilities such as Migrant Health Association in Korea, Dail Angel Hospital, Joseph Clinic, Global Village Love-Sharing, Agape Medical Service, and Dasarang Public Healthcare Development to help the neglected and those requiring medical treatments.

 

One of the staffs of Hanall Bio Pharma has mentioned, “We are grateful for medical service providers who grant medical voluntary services and their effort and concern. Hanall Bio Pharma will also join with the best effort to help our neighbors who need our help.”

 

On the other hand, Hanall is making annual donation from 0.2% of salaries from executives and employees, and the Company is performing various social contribution activities such as free food services, medical aid, domestic and foreign medical volunteer services, organ donation campaign, and blood donation events.